During subsequent follow-up, consistently elevated levels of C8 and C8/C10 were observed, and high-throughput sequencing did not reveal any additional genetic metabolic disorders associated with elevated C8 (including variations in the ETFA, ETFB, and ETFDH genes). This evidence concerns the gene ETFB and Other metabolic disease.